Cyanobacterial microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane B2, cytokines, chemokines, and matrix metalloproteinase-9 by rat microglia

Toxicological Sciences

Volumn 121, Issue 1, 2011, Pages 63-72

  Mayer, Alejandro M S ^a   Clifford, Jonathan A ^a,b   Aldulescu, Monica ^a,b   Frenkel, Jeffrey A ^a,b   Holland, Michael A ^a,b   Hall, Mary L ^a   Glaser, Keith B ^a,c   Berry, John ^d  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c ABBOTT LABORATORIES   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Cyanobacteria; Cytokine; Lipopolysaccharide; Metalloproteinase; Microcystis aeruginosa; Microglia; Superoxide; Thromboxane

Indexed keywords

CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GELATINASE B; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OXYGEN; SUPEROXIDE; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; IN VITRO STUDY; INFLAMMATION; MICROCYSTIS AERUGINOSA; MICROGLIA; NONHUMAN; RAT;

CYANOBACTERIA; ESCHERICHIA COLI; MICROCYSTIS AERUGINOSA; RATTUS;

EID: 79955426421     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr045     Document Type: Article

References (74)

1. Aldulescu, M., Frenkel, J., Hall, M. L., Powell, J. L., Glaser, K. B., and Mayer, A. M. S. (2009). Effect of Microcystis aeruginosa lipopolysaccharide on neonatal brain microglia cytokine and chemokine release. FASEB J. 23, 755.1 (Abstract).
2. Allan, S. M., Tyrrell, P. J., and Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640.
3. Anderson, W. B., Slawson, R. M., and Mayfield, C. I. (2002). A review of drinking-water-associated endotoxin, including potential routes of human exposure. Can. J. Microbiol. 48, 567-587.
4. Banati, R. B., Gehrmann, J., Schubert, P., and Kreutzberg, G. W. (1993). Cytotoxicity of microglia. Glia 7(1), 111-118.
5. Banks, W. A., and Erickson, M. A. (2010). The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 37(1), 26-32.
6. Bernardova, K., Babica, P., Marsalek, B., and Blaha, L. (2008). Isolation and endotoxin activities of lipopolysaccharides from cyanobacterial cultures and complex water blooms and comparison with the effects of heterotrophic bacteria and green alga. J. Appl. Toxicol. 28(1), 72-77.
7. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8(1), 57-69.
8. Candelario-Jalil, E., Yang, Y., and Rosenberg, G. A. (2009). Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158, 983-994.
9. Chao, C. C., Hu, S., Sheng, W. S., Tsang, M., and Peterson, P. K. (1995). Tumor necrosis factor-alpha mediates the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin. Immunol. Immunopathol. 77, 358-365.
10. Choi, S. H., Aid, S., and Bosetti, F. (2009). The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol. Sci. 30(4), 174-181.
11. Colton, C. A. (2009). Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4, 399-418.
12. Colton, C. A., and Gilbert, D. L. (1987). Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 223, 284-288.
13. Colton, C. A., and Wilcock, D. M. (2010). Assessing activation states in microglia. CNS Neurol. Disord. Drug Targets 9(2), 174-191.
14. Colton, C. A., Wilt, S., Gilbert, D., Chernyshev, O., Snell, J., and Dubois-Dalcq, M. (1996). Species differences in the generation of reactive oxygen species by microglia. Mol. Chem. Neuropathol. 28(1-3), 15-20.
15. Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., and Perry, V. H. (2005). Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275-9284.
16. Esen, N., and Kielian, T. (2007). Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs). J. Neuroinflammation. 4, 10.
17. Giulian, D., Baker, T. J., Shih, L. C., and Lachman, L. B. (1986). Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164, 594-604.
18. Gottschall, P. E., Yu, X., and Bing, B. (1995). Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture. J. Neurosci. Res. 42, 335-342.
19. Halliwell, B. (1992). Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
20. Halliwell, B. (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685-716.
21. Harris, V. K., and Sadiq, S. A. (2009). Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol. Diagn. Ther. 13, 225-244.
22. Hausler, K. G., Prinz, M., Nolte, C., Weber, J. R., Schumann, R. R., Kettenmann, H., and Hanisch, U. K. (2002). Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharideand pneumococcal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16, 2113-2122.
23. Hayashi, M., Luo, Y., Laning, J., Strieter, R. M., and Dorf, M. E. (1995). Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J. Neuroimmunol. 60(1-2), 143-150.
24. Hitzfeld, B. C., Hoger, S. J., and Dietrich, D. R. (2000). Cyanobacterial toxins: removal during drinking water treatment, and human risk assessment. Environ. Health Perspect. 108(Suppl. 1), 113-122.
25. Holst, O., Ulmer, A. J., Brade, H., Flad, H. D., and Rietschel, E. T. (1996). Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol. Med. Microbiol. 16(2), 83-104.
26. Horvath, R. J., Nutile-McMenemy, N., Alkaitis, M. S., and Deleo, J. A. (2008). Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J. Neurochem. 107, 557-569.
27. Jurgens, U. J., Martin, C., and Weckesser, J. (1989). Cell wall constituents of microcystis sp. PCC 7806. FEMS Microbiol. Lett. 53(1-2), 47-51.
28. Keleti, G., and Sykora, J. L. (1982). Production and properties of cyanobacterial endotoxins. Appl. Environ. Microbiol. 43(1), 104-109.
29. Kuiper-Goodman, T., Falconer, I., and Fitzgerald, J. (1999). Human health effects. In Toxic Cyanobacteria in Water (I. Chorus and J. Bartram, Eds), pp. 113-153. E and FN Spon, London.
30. Lafrance, V., Inoue, W., Kan, B., and Luheshi, G. N. (2010). Leptin modulates cell morphology and cytokine release in microglia. Brain Behav. Immun. 24, 358-365.
31. Lee, S. C., Liu, W., Dickson, D. W., Brosnan, C. F., and Berman, J. W. (1993). Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J. Immunol. 150, 2659-2667.
32. Maccioni, R. B., Rojo, L. E., Fernandez, J. A., and Kuljis, R. O. (2009). The role of neuroimmunomodulation in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1153, 240-246.
33. Martin, C., Codd, G. A., Siegelman, H. W., and Weckesser, J. (1989). Lipopolysaccharides and polysaccharides of the cell envelope of toxic Microcystis aeruginosa strains. Arch. Microbiol. 152, 90-94.
34. Mayer, A. M. S. (1998). Therapeutic implications of microglia activation by lipopolysaccharide and reactive oxygen species generation in septic shock and central nervous system pathologies: a review. Medicina (B Aires) 58(4), 377-385.
35. 2 generation by the marine manzamines. Inflamm Res. 53, S217 (Abstract).
36. 2, tumor necrosis factor α, and matrix metalloproteases. Toxicol. Sci. 102(Suppl.), 254 (Abstract).
37. 2, and metalloprotease release. Shock 11(3), 180-186.
38. Mayer, A. M. S., and Spitzer, J. A. (1994). Modulation of superoxide generation in in vivo lipopolysaccharide-primed Kupffer cells by staurosporine, okadaic acid, manoalide, arachidonic acid, genistein and sodium orthovanadate. J. Pharmacol. Exp. Ther. 268, 238-247.
39. McCoy, M. K., and Tansey, M. G. (2008). TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation 5, 45.
40. Minghetti, L., and Levi, G. (1995). Induction of prostanoid biosynthesis by bacterial lipopolysaccharide and isoproterenol in rat microglial cultures. J. Neurochem. 65, 2690-2698.
41. Morgenstern, S., Flor, R., Kessler, G., and Klein, B. (1966). Automated determination of NAD-coupled enzymes. Determination of lactic dehydrogenase. Anal. Biochem. 13, 149-161.
42. Nakano, M., Nakano, Y., Saito-Taki, T., Mori, N., Kojima, M., Ohtake, A., and Shirai, M. (1989). Toxicity of Microcystis aeruginosa K-139 strain. Microbiol. Immunol. 33(9), 787-792.
43. Nakano, Y., Shirai, M., Mori, N., and Nakano, M. (1991). Neutralization of microcystin shock in mice by tumor necrosis factor alpha antiserum. Appl. Environ. Microbiol. 57, 327-330.
44. Nishimoto, N. (2010). Interleukin-6 as a therapeutic target in candidate inflammatory diseases. Clin. Pharmacol. Ther. 87, 483-487.
45. Notch, E. G., Miniutti, D. M., Berry, J. P., and Mayer, G. D. (2010). Cyanobacterial LPS potentiates cadmium toxicity in zebrafish (Danio rerio) embryos. Environ. Toxicol. Advance Access published on May 18, 2010; doi:10.1002/tox.20578.
46. Opal, S. M. (2010). Endotoxins and other sepsis triggers. Contrib. Nephrol. 167, 14-24.
47. Patel, N., Clifford, J., Hall, M. L., Glaser, K. B., Jacobson, P., Berry, J., and Mayer, A. M. S. (2010). Effect of Microcystis aeruginosa lipopolysaccharide (LPS) on neonatal rat brain microglia: cytokine expression profiling by antibody array technology. Toxicol. Sci. 114(Suppl.), 161 (Abstract).
48. Peleg, A. Y., and Hooper, D. C. (2010). Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 362, 1804-1813.
49. Perry, V. H., Nicoll, J. A., and Holmes, C. (2010). Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6(4), 193-201.
50. Peterson, P. K., Hu, S., Salak-Johnson, J., Molitor, T. W., and Chao, C. C. (1997). Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J. Infect. Dis. 175, 478-481.
51. Polazzi, E., Altamira, L. E., Eleuteri, S., Barbaro, R., Casadio, C., Contestabile, A., and Monti, B. (2009). Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. J. Neurochem. 110, 545-556.
52. Qian, L., Wei, S. J., Zhang, D., Hu, X., Xu, Z., Wilson, B., El-Benna, J., Hong, J. S., and Flood, P. M. (2008). Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J. Immunol. 181, 660-668.
53. Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J. S., Knapp, D. J., and Crews, F. T. (2007). Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453-462.
54. Ransohoff, R. M., and Perry, V. H. (2009). Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145.
55. Rapala, J., Lahti, K., Rasanen, L. A., Esala, A. L., Niemela, S. I., and Sivonen, K. (2002). Endotoxins associated with cyanobacteria and their removal during drinking water treatment. Water Res. 36, 2627-2635.
56. Raziuddin, S., Siegelman, H. W., and Tornabene, T. G. (1983). Lipopolysaccharides of the cyanobacterium Microcystis aeruginosa. Eur. J. Biochem. 137, 333-336.
57. Rock, R. B., Gekker, G., Hu, S., Sheng, W. S., Cheeran, M., Lokensgard, J. R., and Peterson, P. K. (2004). Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 17, 942-964.
58. Schmidt, V., Drews, G., Weckesser, J., Fromme, I., and Borowiak, D. (1980). Characterization of the lipopolysaccharide from eight strains of the cyanobacterium. Synechococcus. Arch. Microbiol. 127, 209-215.
59. Schultzberg, M., Lindberg, C., Aronsson, A. F., Hjorth, E., Spulber, S. D., and Oprica, M. (2007). Inflammation in the nervous system-physiological and pathophysiological aspects. Physiol. Behav. 92(1-2), 121-128.
60. Sharma, S. K. (1986). Endotoxin detection and elimination in biotechnology. Biotechnol. Appl. Biochem. 8(1), 5-22.
61. Shen, P. P., Zhao, S. W., Zheng, W. J., Hua, Z. C., Shi, Q., and Liu, Z. T. (2003). Effects of cyanobacteria bloom extract on some parameters of immune function in mice. Toxicol. Lett. 143(1), 27-36.
62. Simi, A., Tsakiri, N., Wang, P., and Rothwell, N. J. (2007). Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans. 35, 1122-1126.
63. Sivonen, K., and Jones, G. (1999). Cyanobacterial toxins. In Toxic Cyanobacteria in Water (I. Chorus and J. Bartram, Eds), pp. 41-111. E and FN Spon, London.
64. Slepko, N., Minghetti, L., Polazzi, E., Nicolini, A., and Levi, G. (1997). Reorientation of prostanoid production accompanies "activation" of adult microglial cells in culture. J. Neurosci. Res. 49(3), 292-300.
65. Snyder, D. S., Brahamsha, B., Azadi, P., and Palenik, B. (2009). Structure of compositionally simple lipopolysaccharide from marine. Synechococcus J. Bacteriol. 191, 5499-5509.
66. Stewart, I., Carmichael, W. W., Sadler, R., McGregor, G. B., Reardon, K., Eaglesham, G. K., Wickramasinghe, W. A., Seawright, A. A., and Shaw, G. R. (2009). Occupational and environmental hazard assessments for the isolation, purification and toxicity testing of cyanobacterial toxins. Environ. Health 8, 52.
67. Stewart, I., Schluter, P. J., and Shaw, G. R. (2006). Cyanobacterial lipopolysaccharides and human health-a review. Environ. Health 5, 7.
68. Sun, D., Hu, X., Liu, X., Whitaker, J. N., and Walker, W. S. (1997). Expression of chemokine genes in rat glial cells: the effect of myelin basic protein-reactive encephalitogenic T cells. J. Neurosci. Res. 48(3), 192-200.
69. Szczucinski, A., and Losy, J. (2007). Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol. Scand. 115(3), 137-146.
70. Ubogu, E. E., Cossoy, M. B., and Ransohoff, R. M. (2006). The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27(1), 48-55.
71. Vanlaere, I., and Libert, C. (2009). Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin. Microbiol. Rev. 22(2), 224-239.
72. Walker, D. G., Kim, S. U., and McGeer, P. L. (1995). Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J. Neurosci. Res. 40, 478-493.
73. Weise, G., Drews, G., Jann, B., and Jann, K. (1970). Identification and analysis of a lipopolysaccharide in cell walls of the blue-green alga Anacystis nidulans. Arch. Mikrobiol. 71(1), 89-98.
74. Wiegand, C., and Pflugmacher, S. (2005). Ecotoxicological effects of selected cyanobacterial secondary metabolites: a short review. Toxicol. Appl. Pharmacol. 203, 201-218.